Statement of retraction: Interferon-α2b (IFN-α2b)-induced apoptosis is mediated by p38 MAPK in hepatocytes from rat preneoplastic liver via activation of NADPH oxidase (Growth Factors, (2009), 27, 4, (214–227), 10.1080/08977190902951558);Interferon-α2b (IFN-α2b)-induced apoptosis is mediated by p38 MAPK in hepatocytes from rat preneoplastic liver via activation of NADPH oxidase

Growth Factors

Volumn 27, Issue 4, 2009, Pages 214-227

  Quiroga, Ariel D ^a   de Luján Alvarez, María ^a   Parody, Juan P ^a   Ronco, María T ^a   Carnovale, Cristina E ^a   Carrillo, María Cristina ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Hepatocarcinogenesis; Mitogen activated protein kinases; Oxidative stress; Transforming growth factor 1, p47phox

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHA2B INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA1; ALPHA INTERFERON; ALPHA2 INTERFERON; INTERFERON-ALPHA 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; LIVER CANCER; LIVER CELL CULTURE; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION INITIATION; WISTAR RAT; ANIMAL; GENE EXPRESSION REGULATION; LIVER; LIVER CELL; LIVER TUMOR; METABOLISM;

RATTUS;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; INTERFERON-ALPHA; LIVER; LIVER NEOPLASMS; MALE; NADPH OXIDASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 68449086253     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977194.2020.1792624     Document Type: Erratum

References (45)

1. Alvarez ML, Quiroga AD, Ronco MT, Parody JP, Ochoa JE, Monti JA, et al. 2006. Time-dependent onset of Interferon-alpha2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers. Cytokine 36:245-253.
2. Babior BM. 1999. NADPH oxidase: An update. Blood 93: 1464-1476.
3. Becker S, Reinehr R, Graf D, vom DS, Haussinger D. 2007. Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. Cell Physiol Biochem 19:89-98.
4. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y, et al. 2003. Mechanism of p38 MAP kinase activation in vivo. Genes Dev 17:1969-1978.
5. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA, et al. 2002. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31: 210-215.
6. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, et al. 2004. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36: 343-350.
7. Carreras FI, Gradilone SA, Mazzone A, Garcia F, Huang BQ, Ochoa JE, et al. 2003. Rat hepatocyte aquaporin-8 water channels are down-regulated in extrahepatic cholestasis. Hepatology 37:1026-1033.
8. Chiu C, Maddock DA, Zhang Q, Souza KP, Townsend AR, Wan Y. 2001. TGF-beta-induced p38 activation is mediated by Rac1-regulated generation of reactive oxygen species in cultured human keratinocytes. Int J Mol Med 8:251-255.
9. De Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. 1955. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J 60:604-617.
10. de Lujan AM, Cerliani JP, Monti J, Carnovale C, Ronco MT, Pisani G, et al. 2002. The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein. Hepatology 35: 824-833.
11. de Lujan AM, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, et al. 2004. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40:394-402.
12. Goh KC, Haque SJ, Williams BR. 1999. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J 18:5601-5608.
13. Grethe S, Ares MP, Andersson T, Pörn-Ares MI. 2004. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Exp Cell Res 298:632-642.
14. Gutterman JU. 1994. Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci USA 91:1198-1205.
15. Herrera B, Fernandez M, Roncero C, Ventura JJ, Porras A, Valladares A, et al. 2001. Activation of p38 MAPK by TGF-beta in fetal rat hepatocytes requires radical oxygen production, but is dispensable for cell death. FEBS Lett 499:225-229.
16. Herrera B, Murillo MM, Alvarez-Barrientos A, Beltrán J, Fernández M, Fabregat I. 2004. Source of early reactive oxygen species in the apoptosis induced by transforming growth factorbeta in fetal rat hepatocytes. Free Radic Biol Med 36:16-26.
17. Honmo S, Ozaki A, Yamamoto M, Hashimoto N, Miyakoshi M, Tanaka H, et al. 2007. Low p38 MAPK and JNK activation in cultured hepatocytes of DRH rats; a strain highly resistant to hepatocarcinogenesis. Mol Carcinog 46:758-765.
18. Hortelano S, Dewez B, Genaro AM, az-Guerra MJ, Bosca L. 1995. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 21:776-786.
19. Inanami O, Johnson JL, McAdara JK, Benna JE, Faust LR, Newburger PE, et al. 1998. Activation of the leukocyte NADPH oxidase by phorbol ester requires the phosphorylation of p47PHOX on serine 303 or 304. J Biol Chem 273: 9539-9543.
20. Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. 2000. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41-48.
21. Jones SA, Hancock JT, Jones OT, Neubauer A, Topley N. 1995. The expression of NADPH oxidase components in human glomerular mesangial cells: Detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 5: 1483-1491.
22. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OT. 1996. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 271: H1626-H1634.
23. Juretic N, Santibáñez JF, Hurtado C, Martínez J. 2001. ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. J Cell Biochem 83:92-98.
24. Klimpel GR, Infante AJ, Patterson J, Hess CB, Asuncion M. 1990. Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: A study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations. Cell Immunol 128:603-618.
25. Lambeth JD. 2004. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181-189.
26. Liu B, Fang M, Lu Y, Lu Y, Mills GB, Fan Z. 2001. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. Br J Cancer 85:303-311.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
28. Mayer IA, Verma A, Grumbach IM, Uddin S, Lekmine F, Ravandi F, et al. 2001. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J Biol Chem 276:28570-28577.
29. Murillo MM, Carmona-Cuenca I, Del CG, Ortiz C, Roncero C, Sanchez A, et al. 2007. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism. Biochem J 405: 251-259.
30. Nakagami H, Morishita R, Yamamoto K, Yoshimura SI, Taniyama Y, Aoki M. 2001. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50:1472-1481.
31. Park JM, Greten FR, Li ZW, Karin M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-2051.
32. Platanias LC. 2003. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 98: 129-142.
33. Porras A, Zuluaga S, Black E, Valladares A, Alvarez AM, et al. 2004. p38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 15: 922-933.
34. Quiroga AD, Alvarez ML, Parody JP, Ronco MT, Frances DE, Pisani GB, et al. 2007. Involvement of reactive oxygen species on the apoptotic mechanism induced by IFN-alpha2b in rat preneoplastic liver. Biochem Pharmacol 73:1776-1785.
35. Razandi M, Pedram A, Levin ER. 2000. Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 275:38540-38546.
36. Reinehr R, Becker S, Eberle A, Grether-Beck S, Haussinger D. 2005. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280:27179-27194.
37. Sarkar D, Su ZZ, Lebedeva IV, Sauane M, Gopalkrishnan RV, Valerie K, et al. 2002. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc Natl Acad Sci USA 99:10054-10059.
38. Seglen PO. 1973. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82:391-398.
39. Spizz G, Blackshear PJ. 1996. Protein kinase C-mediated phosphorylation of the myristoylated alanine-rich C-kinase substrate protects it from specific proteolytic cleavage. J Biol Chem 271:553-562.
40. Tada S, Saito H, Tsunematsu S, Ebinuma H, Wakabayashi K, Masuda T, et al. 1998. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines. Int J Oncol 13:1207-1216.
41. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270: 30334-30338.
42. Uddin S, Majchrzak B, Woodson J, Arunkumar P, Alsayed Y, Pine R, et al. 1999. Activation of the p38 mitogen-activated protein kinase by type I interferons. J Biol Chem 274:30127-30131.
43. Uddin S, Lekmine F, Sharma N, Majchrzak B, Mayer I, Young PR, et al. 2000. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J Biol Chem 275:27634-27640.
44. Verma A, Deb DK, Sassano A, Uddin S, Varga J, Wickrema A, Platanias LC. 2002. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J Biol Chem 277:7726-7735.
45. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. 2001. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38 MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268: 6058-6065.